Literature DB >> 24396253

Nasal congestion with iloperidone therapy in a case series.

Saibal Das1, Indranil Saha2, Somnath Mondal3, Sanjib Bandyopadhyay4.   

Abstract

Entities:  

Year:  2013        PMID： 24396253      PMCID： PMC3812889          DOI： 10.1016/j.jyp.2013.08.003

Source DB:  PubMed          Journal:  J Young Pharm        ISSN： 0975-1483


× No keyword cloud information.
  5 in total

Review 1.  Advances in atypical antipsychotics for the treatment of schizophrenia: new formulations and new agents.

Authors:  James P Kelleher; Franca Centorrino; Matthew J Albert; Ross J Baldessarini
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.

Authors:  Steven G Potkin; Robert E Litman; Rosarelis Torres; Curt D Wolfgang
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

3.  Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.

Authors:  Andrew J Cutler; Amir H Kalali; Peter J Weiden; Jennifer Hamilton; Curt D Wolfgang
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

4.  Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.

Authors:  Peter J Weiden; Andrew J Cutler; Mihael H Polymeropoulos; Curt D Wolfgang
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

5.  Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.

Authors:  John M Kane; John Lauriello; Eugene Laska; Michael Di Marino; Curt D Wolfgang
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153
  5 in total
  1 in total

Review 1.  Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy.

Authors:  Fernanda S Tonin; Astrid Wiens; Fernando Fernandez-Llimos; Roberto Pontarolo
Journal:  Core Evid       Date:  2016-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.